TrialBlood2018

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.

Lauren P McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.